Control of physical properties in BiFeO3nanoparticles via Sm3+and Co2+ion doping.

Highly crystalline BiFeO3(BFO), Bi0.97Sm0.03FeO3(Sm-BFO) and BiFe0.97Co0.03O3(Co-BFO) nanoparticles (NPs) were utilized as potential magnetic hyperthermia agents at two different frequencies in the radiofrequency (RF) range, and the effect of Sm3+and Co2+ion doping on the physical properties of the material was examined. The thermal behaviour of the as-prepared powders disclosed that the crystallization temperature of the powders is affected by the incorporation of the dopants into the BFO lattice and the Curie transition temperature is decreased upon doping. Vibrational analysis confirmed the formation of the R3c phase in all compounds through the characteristic FT-IR absorbance bands assigned to O-Fe-O bending vibration and Fe-O stretching of the octahedral FeO6group in the perovskite, as well as through Raman spectroscopy. The shift of the Raman-active phonon modes in Sm-BFO and Co-BFO NPs indicated structural distortion of the BFO lattice, which resulted in increased local polarization and enhanced visible light absorption. The aqueous dispersion of Co-BFO NPs showed the highest magnetic hyperthermia performance at 30 mT/765 kHz, entering the therapeutic temperature window for cancer treatment, whereas the heating efficiency of all samples was increased with increasing frequency from 375 to 765 kHz, making our doped nanoparticles to be suitable candidates for potential biomedical applications.

Toward the Separation of Different Heating Mechanisms in Magnetic Particle Hyperthermia.

Magnetic particle hyperthermia (MPH) is a promising method for cancer treatment using magnetic nanoparticles (MNPs), which are subjected to an alternating magnetic field for local heating to the therapeutic range of 41-45 °C. In this window, the malignant regions (i.e., cancer cells) undergo a severe thermal shock while healthy tissues sustain this thermal regime with significantly milder side effects. Since the heating efficiency is directly associated with nanoparticle size, MNPs should acquire the appropriate size to maximize heating together with minimum toxicity. Herein, we report on facile synthetic controls to synthesize MNPs by an aqueous precipitation method, whereby tuning the pH values of the solution (9.0-13.5) results in a wide range of average MNP diameters from 16 to 76 nm. With respect to their size, the structural and magnetic properties of the MNPs are evaluated by adjusting the most important parameters, i.e. the MNP surrounding medium (water/agarose), the MNP concentration (1-4 mg mL-1), and the field amplitude (20-50 mT) and frequency (103, 375, 765 kHz). Consequently, the maximum heating efficiency is determined for each MNP size and set of parameters, outlining the optimum MNPs for MPH treatment. In this way, we can address the different heat generation mechanisms (Brownian, Néel, and hysteresis losses) to different sizes and separate Brownian and hysteresis losses for optimized sizes by studying the heat generation as a function of the medium viscosity. Finally, MNPs immobilized into agarose solution are studied under low-field MPH treatment to find the optimum conditions for clinical applications.

Hybrid Stents Based on Magnetic Hydrogels for Biomedical Applications.

Tremendous attention has been given to hydrogels due to their mechanical and physical properties. Hydrogels are promising biomaterials due to their high biocompatibility. Magnetic hydrogels, which are based on hydrogel incorporated magnetic nanoparticles, have been proposed in biomedical applications. The advantages of magnetic hydrogels are that they can easily respond to externally applied magnetic fields and prevent the leakage of magnetic nanoparticles in the surrounding area. Herein, a prototype hybrid stent of magnetic hydrogel was fabricated, characterized, and evaluated for magnetic hyperthermia treatment. First, magnetic hydrogel was produced by a solution of alginate with magnetic nanoparticles in a bath of calcium chloride (5-15 mg mL-1) in order to achieve the external gelation and optimize the heating rate. The increased concentration (1-8 mg mL-1) of magnetic nanoparticles inside the hydrogel resulted in almost zero leakage of iron oxide nanoparticles after 15 days, guaranteeing that they can be used safely in biomedical applications. Thus, magnetic hybrid stents, which are based on the magnetic hydrogels, were developed in a simple way and were evaluated both in an agarose phantom model and in an ex vivo tissue sample at 30 mT and 765 kHz magnetic hyperthermia conditions to examine the heating efficiency. In both cases, hyperthermia results indicate excellent heat generation from the hybrid stent and facile temperature control via tuning magnetic nanoparticle concentration (2-8 mg mL-1). This study can be a promising method that promotes spatially thermal distribution in cancer treatment or restenosis treatment of hollow organs.

Long-Range Ordering Effects in Magnetic Nanoparticles.

The challenge for synthesizing magnetic nanoparticle chains may be achieved under the application of fixation fields, which are the externally applied fields, enhancing collective magnetic features due to adequate control of dipolar interactions among magnetic nanoparticles. However, relatively little attention has been devoted to how size, concentration of magnetic nanoparticles, and intensity of an external magnetic field affect the evolution of chain structures and collective magnetic features. Here, iron oxide nanoparticles are developed by the coprecipitation method at diameters below (10 and 20 nm) and above (50 and 80 nm) their superparamagnetic limit (at about 25 nm) and then are subjected to a tunable fixation field (40-400 mT). Eventually, the fixation field dictates smaller particles to form chain structures in two steps, first forming clusters and then guiding chain formation via "cluster-cluster" interactions, whereas larger particles readily form chains via "particle-particle" interactions. In both cases, dipolar interactions between the neighboring nanoparticles augment, leading to a substantial increase in their collective magnetic features which in turn results in magnetic particle hyperthermia efficiency enhancement of up to one order of magnitude. This study provides new perspectives for magnetic nanoparticles by arranging them in chain formulations as enhanced performance magnetic actors in magnetically driven magnetic applications.

Mitigation of magnetic particle hyperthermia side effects by magnetic field controls.

Objective: In magnetic particle hyperthermia, a promising least-invasive cancer treatment, malignant regions in proximity with magnetic nanoparticles undergo heat stress, while unavoidably surrounding healthy tissues may also suffer from heat either directly or indirectly by the induced eddy currents, due to the developed electric fields as well. Here, we propose a facile upgrade of a typical magnetic particle hyperthermia protocol, to selectively mitigate eddy currents' heating without compromising the beneficial role of heating in malignant regions.Method: The key idea is to apply the external magnetic field intermittently (in an ON/OFF pulse mode), instead of the continuous field mode typically applied. The parameters of the intermittent field mode, such as time intervals (ON time: 25-100 s, OFF time: 50-200 s, Duty Cycle:16-100%) and field amplitude (30-70 mT) are optimized based on evaluation on healthy tissue and cancer tissue phantoms. The goal is to sustain in cancer tissue phantom the maximum temperature increase (preferably within 4-8°C above body temperature of 37°C), while in the healthy tissue phantom temperature variation is suppressed far below the 4°C dictating the eddy current mitigation.Results: Optimum conditions of intermittent field (ON/OFF: 50/100 in s, Duty Cycle: 33%, magnetic field: 45mT) are then examined in ex-vivo samples verifying the successful suppression of eddy currents. Simultaneously, a well-elaborated theoretical approach provides a rapid calculation of temperature increase and, furthermore, the ability to quickly simulate a variety of duty cycle times and field controls may save experimental time.Conclusion: Eventually, the application of an intermittent field mode in a magnetic particle hyperthermia protocol, succeeds in eddy current mitigation in surrounding tissues and allows for the application of larger field amplitudes that may augment hyperthermia efficiency without objecting typical biomedical applicability field constraints such as Brezovich criterion.

Temperature-controlled magnetic nanoparticles hyperthermia inhibits primary tumor growth and metastases dissemination.

Magnetic hyperthermia (MHT) is a promising approach for cancer therapy. However, a systematic MHT characterization as function of temperature on the therapeutic efficiency is barely analyzed. Here, we first perform comparative temperature-dependent analysis of the cobalt ferrite nanoparticles-mediated MHT effectiveness in two murine tumors models - breast (4T1) and colon (CT26) cancer in vitro and in vivo. The overall MHT killing capacity in vitro increased with the temperature and CT26 cells were more sensitive than 4T1 when heated to 43 °C. Well in line with the in vitro data, such heating cured non-metastatic CT26 tumors in vivo, while only inhibiting metastatic 4T1 tumor growth without improving the overall survival. High-temperature MHT (>47 °C) resulted in complete 4T1 primary tumor clearance, 25-40% long-term survival rates, and, importantly, more effective prevention of metastasis comparing to surgical extraction. Thus, the specific MHT temperature must be defined for each tumor individually to ensure a successful antitumor therapy.

Spatial focusing of magnetic particle hyperthermia.

Magnetic particle hyperthermia is a promising cancer therapy, but a typical constraint of its applicability is localizing heat solely to malignant regions sparing healthy surrounding tissues. By simultaneous application of a constant magnetic field together with the hyperthermia inducing alternating magnetic field, heating focus may be confined to smaller regions in a tunable manner. The main objective of this work is to evaluate the focusing parameters, by adequate selection of magnetic nanoparticles and field conditions, and explore spatially focused magnetic particle hyperthermia efficiency in tissue phantom systems comprising agarose gel and magnetic nanoparticles. Our results suggest the possibility of spatially focused heating efficiency of magnetic nanoparticles through the application of a constant magnetic field. Tuning of the constant magnetic field parameters may result in minimizing thermal shock in surrounding regions without affecting the beneficiary thermal outcome in the focusing region.

Size-selected Fe3O4-Au hybrid nanoparticles for improved magnetism-based theranostics.

Size-selected Fe3O4-Au hybrid nanoparticles with diameters of 6-44 nm (Fe3O4) and 3-11 nm (Au) were prepared by high temperature, wet chemical synthesis. High-quality Fe3O4 nanocrystals with bulk-like magnetic behavior were obtained as confirmed by the presence of the Verwey transition. The 25 nm diameter Fe3O4-Au hybrid nanomaterial sample (in aqueous and agarose phantom systems) showed the best characteristics for application as contrast agents in magnetic resonance imaging and for local heating using magnetic particle hyperthermia. Due to the octahedral shape and the large saturation magnetization of the magnetite particles, we obtained an extraordinarily high r 2-relaxivity of 495 mM-1·s-1 along with a specific loss power of 617 W·gFe -1 and 327 W·gFe -1 for hyperthermia in aqueous and agarose systems, respectively. The functional in vitro hyperthermia test for the 4T1 mouse breast cancer cell line demonstrated 80% and 100% cell death for immediate exposure and after precultivation of the cells for 6 h with 25 nm Fe3O4-Au hybrid nanomaterials, respectively. This confirms that the improved magnetic properties of the bifunctional particles present a next step in magnetic-particle-based theranostics.